Top Markets
Coin of the day
Anatara Lifesciences Ltd Anatara Lifesciences Ltd

Anatara Lifesciences Ltd

ANR
Rang in Aktien #37961
Anatara Lifesciences Ltd is an Australian enterprise focused on researching,... Anatara Lifesciences Ltd is an Australian enterprise focused on researching, developing, and commercializing scientifically-validated therapies for digestive system ailments affecting both humans and animals. Its product portfolio includes Gastrointestinal ReProgramming (GRP), a proprietary blend combining bromelain with other evidence-based ingredients, specifically formulated to target the underlying issues of human gastrointestinal conditions such as irritable bowel syndrome and inflammatory bowel disease. The firm also offers 3FDC, designed to address anxiety, stress, or depression. In the animal health sector, Anatara provides Detach for treating diarrhea in piglets, BONIFF as an enhanced dry feed formulation for weaned piglets, and ANR-pf, a unique additive for poultry drinking water. This company was founded in 2010 and is headquartered in Carlton, Australia.
Aktienkurs
$0.00634756
Zuletzt synchronisiert: 2026-08-14
Marktkapitalisierung
$1.32M
Veränderung (1 Tag)
0.00%
Veränderung (1 Jahr)
39.40%
Land
AU
Handel Anatara Lifesciences Ltd (ANR)

Kategorie

Kursverlauf für Anatara Lifesciences Ltd (ANR)
Höchster Schlusskurs: $0.01 am 2026-08-01

Niedrigster Schlusskurs: $0.30 am 2014-10-01
Kursverlauf der Aktie von Anatara Lifesciences Ltd von 2014 bis 2026
Jährliche Kursentwicklung
Jahr Leistung
2026 (TTM) -22.79%
2025 -72.86%
2024 90.01%
2023 -27.71%
2022 -75.63%
2021 -23.04%
2020 -9.27%
2019 -54.84%
2018 -75.62%
2017 69.25%
2016 11.01%
2015 165.72%
2014 0.00%
Aktienkurs vergleichbarer Unternehmen oder Wettbewerber
Unternehmen Aktienkurs Veränderung 1J% Land
$505.24 28.63%
US
$846.09 29.41%
NL
$731.69 6.47%
CH
$1.07K -6.40%
KR
$251.82 11.75%
BE